Animal platelets structure

Blood)platelet activating/actor a physiologically active ether lipid (alkoxylipid) that was first isolated from blood leukocytes. PAF is formed in many animal tissues as the result of an external stimulus and has the character of a hormone (so-called mediator). The chemical structure of PAF was elucidated in 1979 as a mixture of l-0-alkyl-2-0-acetyl-sn-glycero-3-phos-phocholines. PAF effects the aggregation of blood... 

The effect of NAMPT inhibitors on platelets isolated from healthy human donors was also investigated. None of the three structurally distinct NAMPT inhibitors had an effect on platelet bioenergetics, aggregation, or activation up to a concentration of 50 pM, suggesting that the clinical thrombocytopenia was mainly due to effects on platelet production by megakaryocytes rather than effects on platelets (Tarrant et al., 2015). This approach illustrates the successful use of in vitro systems of primary human cells to recapitulate human toxicities when animals are not suitable models in order to evaluate MOT and also toxicity mitigation strategies. 

Because blood is a multicomponeiit system containing a large number of ionized and molecular species differing in size, mass, cell structure, and coUoidal particles, several processes such as polymerization of blood proteins, reaction with biosurfactants, and other accompanying processes besides adsorption can take place on the surface of adsorbent carbon. These processes can influence the adsorptive removal of toxics and other harmful components from blood during hemoperfusion. Furthermore, experiments concerning destraction of thrombocytes and deposition of platelets and leucocytes on the adsorbent carbon surface can only be carried out on animal blood. 

---